课题基金 / 基金详情

New approach for the elucidation of the etiology of Kawasaki disease

New approach for the elucidation of the etiology of Kawasaki disease
阐明川崎病病因的新方法
批准号:
22591190
负责人:
SUZUKI Hiroyuki
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

SUZUKI Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We collected the samples of throat swab from 58 patients who met the diagnostic criteria for Kawasaki disease and were admitted to our hospitals. Bacteria from throat swab were cultured in liquid culture solution (Brain-Heart-Infusion). W e extracted total DNA from those bacteria using DNA Mini Kit (QIAGEN). Using total DNA extracted from bacteria as a template, polymerase chain reaction (PCR) was performed for 5 SAg genes-streptococcal pyrogenic exotoxin type A(SPE-A), SPE-C, SPE-G, SPE-J, and toxic shock syndrome toxin-1 (TSST -1). SPE-G gene and SPE-J gene were detected in 7 and 6 of 58 patients, respectively. Both SPE-G gene and SPE-J gene were detected in one of 58 patients. Thus, gene fragments of superantigens derived from group A streptococcus (GAS) were detected in the samples of throat swabs from 12 of 58 patients (20.7%). These results were reproducted and very important. However, GAS was not detected from any patients in whom SPE-G and SPE-J gene were detected. Thus, it is very important point and the theme in this study that any kind of bacteria have these superantigen genes. Unfortunately, we could not isolate the bacteria in this study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IVIG 不応川崎病症例に対する CsA 療法時の血中カリウム濃度の検討
IVIG难治性川崎病患者 CsA 治疗期间血钾浓度的检测
DOI: --
发表时间: 2012
期刊: Prog Med
影响因子: --
作者: [垣本信幸, 鈴木啓之, 末永智浩, 武内 崇, 吉川徳茂, 渋田昌一, 濱田洋通, 本田隆文, 寺井 勝, 笹子久美子, 尾内善広, 鈴木洋一, 羽田 明]
通讯作者: 羽田 明
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [小西行彦, 他, 金子 一成, 鈴木啓之]
通讯作者: 鈴木啓之
川崎病は溶連菌毒素を中心とするスーパー抗原病? ランチョンセミナー:「川崎病の病因解明の最前線」
川崎病是一种以链球菌毒素为中心的超抗原疾病吗?午宴研讨会:《阐明川崎病发病机制的最前沿》
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Ogawa T, Kuwagata M, 他5名, 鈴木啓之]
通讯作者: 鈴木啓之
IVIG 不応の川崎病症例に対するシクロスポリン A 療法
环孢素 A 治疗 IVIG 难治性川崎病病例
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Yamaoka S, Ogihara T, Yasui M, Hasegawa M, Hira S, Oue S, Ubukata K, Watanabe H, Takahashi T, 亀井良政, 田中 英高., 鈴木啓之]
通讯作者: 鈴木啓之
26
    Role of THG-1 in squamous cell carcinoma development and its application to cancer therapy
    Development of therapy for craniosynostosis in Apert syndrome by FGF signal control
    • 批准号:
      24890063
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.91万
    • 财政年份:
      2012
    • 负责人:
      SUZUKI Hiroyuki
    • 依托单位:
    Study on the Historical Process of Forming "Japanese Art History" Through the Comparison of Nineteenth-Century Japan, Europe, and the United States
    • 批准号:
      24520103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2012
    • 负责人:
      SUZUKI Hiroyuki
    • 依托单位:
    Study on Fire Resistance Design of Steel Frames taking Deformation and Redundancy into account
    • 批准号:
      23360240
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.73万
    • 财政年份:
      2011
    • 负责人:
      SUZUKI Hiroyuki
    • 依托单位:
    国内基金
    海外基金
    脾脏巨噬细胞糖酵解重编程促进细胞活化及MMP9表达介导川崎病炎症反应和冠状动脉病变的机制研究
    NLRP3炎症小体与NF-κB通路在川崎病冠状动脉炎中的串扰机制及靶向干预研究
    • 批准号:
      JCZRLH202601528
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    维生素D₃/VDR介导单核细胞代谢重编程减轻川崎病冠脉损伤的机制研究
    • 批准号:
      JCZRLH202600458
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    肠道微生物通过NLRP3/IL-1β通路介导血管内皮损伤在川崎病及其冠状动脉病变中的作用机制研究
    • 批准号:
      JCZRLH202500452
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位: